Dr. Falk Pharma Tech Stack

Specialty pharma focused on gastrointestinal and hepatic disorders

Pharmaceutical Manufacturing Freiburg im Breisgau, Baden-Württemberg 201–500 employees Privately Held

Dr. Falk Pharma is a family-owned pharmaceutical manufacturer with 60+ years in digestive and metabolic medicine, operating across 10 European and Australian affiliates with R&D and manufacturing hubs in Germany, France, Italy, and Switzerland. The tech stack (SAP S/4HANA, Veeva Vault, DocuSign) reflects mature pharma operations, while active hiring across clinical research, quality, and product roles—concentrated in Germany—signals expansion of pipeline development and regulatory infrastructure rather than geographic scaling.

Tech Stack 16 technologies

Core StackDocuSign SAP S/4HANA Adobe Premiere Pro After Effects Adobe Illustrator Adobe Creative Cloud TYPO3 Word Microsoft 365 Microsoft Office Veeva Vault Photoshop Cinema 4D Blender SharePoint Teams

What Dr. Falk Pharma Is Building

◆Challenges

Ensuring pharmacovigilance compliance
Vendor onboarding
Budget monitoring
Digitalization and process optimization in finance
Managing safety operations
Feasibility assessment
Site selection
Audit readiness
Capa management
Managing risk management plans

▲Active Projects

International phase i clinical studies
Relaunch of brand design system
Budget monitoring and vendor payment processes
Redaktion eines englischsprachigen fachjournals
Creation and maintenance of sops
Qualifizierung potenzieller neuprojekte
Entwicklungsplanerstellung und risikobewertung
Koordination externer entwicklungsaktivitäten
Global medical affairs strategy for ibd, eoe, hep
Establish medical advisory boards

Hiring Activity

Accelerating35 roles · 15 in 30d

Department

Logistics

Ops

Research

Healthcare

Marketing

Product

Quality

Seniority

Intern

Manager

Mid

Junior

Senior

Director

Lead

Notable leadership hires: Safety Product Lead

Company intelligence

Find more companies like Dr. Falk Pharma by tech stack, pain points and active projects

Get started free

About Dr. Falk Pharma

Dr. Falk Pharma develops and manufactures medicines for inflammatory bowel disease, eosinophilic esophagitis, primary biliary cholangitis, and related gastrointestinal and hepatobiliary disorders. The company employs approximately 1,550 people globally, with 450 based in Freiburg headquarters. Manufacturing is distributed across four European countries (Germany, France, Italy, Switzerland). Current operational priorities include pharmacovigilance compliance, site selection, vendor onboarding, and audit readiness—typical of a mid-sized pharma firm scaling clinical programs and tightening regulatory controls.

HeadquartersFreiburg im Breisgau, Baden-Württemberg

Company Size201–500 employees

Hiring MarketsGermany

Frequently Asked Questions

What technology does Dr. Falk Pharma use?

Core systems include SAP S/4HANA for ERP, Veeva Vault for document and data management, and DocuSign for contract workflows. Creative and publishing tools span Adobe Creative Cloud (Photoshop, Premiere Pro, Illustrator) and 3D software (Cinema 4D, Blender). Collaboration runs on Microsoft 365 and Teams.

Where is Dr. Falk Pharma headquartered?

Freiburg im Breisgau, Baden-Württemberg, Germany. The company operates R&D and manufacturing sites in Germany, France, Italy, and Switzerland, plus 10 affiliates across Europe and Australia.